chr11-1840938-C-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_003282.4(TNNI2):c.276+30C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.251 in 1,602,912 control chromosomes in the GnomAD database, including 52,643 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.21 ( 3859 hom., cov: 33)
Exomes 𝑓: 0.26 ( 48784 hom. )
Consequence
TNNI2
NM_003282.4 intron
NM_003282.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.109
Genes affected
TNNI2 (HGNC:11946): (troponin I2, fast skeletal type) This gene encodes a fast-twitch skeletal muscle protein, a member of the troponin I gene family, and a component of the troponin complex including troponin T, troponin C and troponin I subunits. The troponin complex, along with tropomyosin, is responsible for the calcium-dependent regulation of striated muscle contraction. Mouse studies show that this component is also present in vascular smooth muscle and may play a role in regulation of smooth muscle function. In addition to muscle tissues, this protein is found in corneal epithelium, cartilage where it is an inhibitor of angiogenesis to inhibit tumor growth and metastasis, and mammary gland where it functions as a co-activator of estrogen receptor-related receptor alpha. This protein also suppresses tumor growth in human ovarian carcinoma. Mutations in this gene cause myopathy and distal arthrogryposis type 2B. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 11-1840938-C-T is Benign according to our data. Variant chr11-1840938-C-T is described in ClinVar as [Benign]. Clinvar id is 259023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-1840938-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.253 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNNI2 | NM_003282.4 | c.276+30C>T | intron_variant | Intron 6 of 7 | ENST00000381911.6 | NP_003273.1 | ||
TNNI2 | NM_001145829.2 | c.276+30C>T | intron_variant | Intron 6 of 7 | NP_001139301.1 | |||
TNNI2 | NM_001145841.2 | c.276+30C>T | intron_variant | Intron 4 of 5 | NP_001139313.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.211 AC: 32116AN: 151862Hom.: 3857 Cov.: 33
GnomAD3 genomes
AF:
AC:
32116
AN:
151862
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.248 AC: 56394AN: 227494Hom.: 7361 AF XY: 0.252 AC XY: 31315AN XY: 124354
GnomAD3 exomes
AF:
AC:
56394
AN:
227494
Hom.:
AF XY:
AC XY:
31315
AN XY:
124354
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.255 AC: 370100AN: 1450936Hom.: 48784 Cov.: 37 AF XY: 0.256 AC XY: 184262AN XY: 721096
GnomAD4 exome
AF:
AC:
370100
AN:
1450936
Hom.:
Cov.:
37
AF XY:
AC XY:
184262
AN XY:
721096
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.211 AC: 32119AN: 151976Hom.: 3859 Cov.: 33 AF XY: 0.217 AC XY: 16125AN XY: 74294
GnomAD4 genome
AF:
AC:
32119
AN:
151976
Hom.:
Cov.:
33
AF XY:
AC XY:
16125
AN XY:
74294
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 26, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: -2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at